@marcsaric

Passive immunotherapeutic strategies for the treatment of malignant gliomas

, , , , , , and . Neurosurg Clin N Am, 23 (3): 481-495 (July 2012)
DOI: 10.1016/j.nec.2012.04.008

Abstract

This review provides historical and recent perspectives related to passive immunotherapy for high-grade gliomas. The authors discuss approaches that use lymphokine-activated killer cells, cytotoxic T lymphocytes, and monoclonal antibodies.

Description

Passive Immunotherapeutic Strategies for the Treatment of Malignant Gliomas

Links and resources

Tags